Nektar Therapeutics | NKTR - Ebit

Stock Price
85.03
Daily Change
0.87 1.03%
Monthly
11.53%
Yearly
836.04%
Q2 Forecast
84.66

Nektar Therapeutics reported $-19.09M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Agios Pharmaceuticals USD -110.02M 11.55M Mar/2026
ALKERMES USD -48.28M 37.33M Mar/2026
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 3.83B 130M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
BioCryst Pharmaceuticals USD 260.38M 230.79M Dec/2025
Biogen USD 514.3M 502.8M Mar/2026
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
Cara Therapeutics USD -5.94M 3.55M Sep/2025
Cipla INR 9.77B 6.21B Dec/2025
Dr.Reddys Laboratories INR 13.94B 1.79B Dec/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Esperion Therapeutics USD 85.23M 95.19M Dec/2025
Exelixis USD 251.34M 15.43M Mar/2026
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Grifols EUR 320.55M 91.01M Dec/2025
Halozyme Therapeutics USD -88.41M 306.33M Dec/2025
Incyte USD 344.17M 39.71M Mar/2026
Ionis Pharmaceuticals USD -118M 97M Mar/2026
Ironwood Pharmaceuticals USD 33.22M 7.58M Dec/2024
Karyopharm Therapeutics USD -17.84M 8.44M Dec/2025
MacroGenics USD -12.1M 32.26M Dec/2025
Merck USD -1.88B 8.12B Mar/2026
Nektar Therapeutics USD -19.09M 15.26M Dec/2025
Neurocrine Biosciences USD 214.6M 13.3M Mar/2026
Novartis USD 4.18B 118M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Sarepta Therapeutics USD -410.08M 347.2M Dec/2025
Takeda JPY 257.49B 568.56B Dec/2025
Teva Pharmaceutical Industries USD 758M 181M Mar/2026
Xencor USD -53.63M 6.11M Dec/2025